Crystal structure of a chimeric Fab′ fragment of an antibody binding tumour cells
R.L. Brady(Bristol Institute for Transfusion Sciences), Dominic Löw(UCB Pharma (United Kingdom)), Gudrun Lange(University of York), Jiahao Jiang(Wuhan University), Roderick E. Hubbard(University of York), R. Todd(University of York), David J. King(Regulus Therapeutics (United States)), David J. Edwards(University of York), Sheree Roberts(University of York), John R. Adair(UCB Pharma (United Kingdom)), J.S. Emtage
Cited by 44
Related Papers
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
|Molecular Immunology|1993|243